Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Axsome Thera (AXSM)

Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,368,291
  • Shares Outstanding, K 47,374
  • Annual Sales, $ 270,600 K
  • Annual Income, $ -239,240 K
  • 60-Month Beta 1.13
  • Price/Sales 11.89
  • Price/Cash Flow N/A
  • Price/Book 16.28
Trade AXSM with:

Options Overview Details

View History
  • Implied Volatility 50.47% ( -0.60%)
  • Historical Volatility 49.19%
  • IV Percentile 33%
  • IV Rank 28.77%
  • IV High 79.21% on 05/01/23
  • IV Low 38.87% on 09/14/23
  • Put/Call Vol Ratio 0.09
  • Today's Volume 802
  • Volume Avg (30-Day) 948
  • Put/Call OI Ratio 0.74
  • Today's Open Interest 20,042
  • Open Int (30-Day) 24,298

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -1.21
  • Number of Estimates 7
  • High Estimate -0.99
  • Low Estimate -1.33
  • Prior Year -0.22
  • Growth Rate Est. (year over year) -450.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.50 +11.57%
on 04/19/24
83.89 -12.89%
on 03/25/24
-7.58 (-9.40%)
since 03/22/24
3-Month
65.50 +11.57%
on 04/19/24
98.40 -25.73%
on 02/12/24
-16.44 (-18.36%)
since 01/23/24
52-Week
55.02 +32.82%
on 11/13/23
98.40 -25.73%
on 02/12/24
+0.16 (+0.22%)
since 04/21/23

Most Recent Stories

More News
Billionaires Are Buying These 2 Ultra-High Yield Dividend Stocks Hand Over Fist. Are They Smart Buys for Your Portfolio?

Stocks that work for billionaires aren't necessarily appropriate for every investor.

PLTR : 21.64 (+3.20%)
AXSM : 73.08 (+2.78%)
TMDX : 90.60 (+4.73%)
HTGC : 18.85 (+0.86%)
MO : 42.87 (+0.70%)
2 Under-the-Radar Growth Stocks to Consider

Don't ignore these innovative companies.

MDGL : 218.38 (+2.29%)
AXSM : 73.08 (+2.78%)
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

The price could be right for these three biopharma stocks.

AXSM : 73.08 (+2.78%)
CRSP : 56.41 (+1.35%)
PFE : 26.32 (+0.23%)
3 Biotech Stocks to Buy and Hold for the Next 10 Years

There's a lot to like about these three drugmakers right now, and that shouldn't stop anytime soon.

CRSP : 56.41 (+1.35%)
AXSM : 73.08 (+2.78%)
AMGN : 273.54 (+0.60%)
Axsome Therapeutics (AXSM) Q4 2023 Earnings Call Transcript

AXSM earnings call for the period ending December 31, 2023.

AXSM : 73.08 (+2.78%)
Enpro, Axsome Therapeutics fall; Walmart, Medtronic rise, Tuesday, 2/20/2024

Stocks that traded heavily or had substantial price changes on Tuesday: Enpro, Axsome Therapeutics fall; Walmart, Medtronic rise

AXSM : 73.08 (+2.78%)
TCMD : 14.57 (-0.55%)
Axsome: Q4 Earnings Snapshot

Axsome: Q4 Earnings Snapshot

AXSM : 73.08 (+2.78%)
2 Stocks That Could Double Your Money in 5 Years

These market-beating stocks could be just getting started.

SHOP : 74.01 (+4.90%)
AXSM : 73.08 (+2.78%)
3 Stocks That Have Turned $50,000 Into More Than $500,000 in Just 5 Years

Is it too late to invest in these fast-growing stocks?

NVDA : 824.23 (+3.65%)
TSLA : 144.68 (+1.85%)
AXSM : 73.08 (+2.78%)
2 Biotech Stocks You Can Buy and Hold for the Next Decade

The types of innovative drugs these companies develop are always in high demand.

ABBV : 169.54 (+0.98%)
AXSM : 73.08 (+2.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available.

See More

Key Turning Points

3rd Resistance Point 76.69
2nd Resistance Point 73.99
1st Resistance Point 72.55
Last Price 73.08
1st Support Level 68.41
2nd Support Level 65.71
3rd Support Level 64.27

See More

52-Week High 98.40
Fibonacci 61.8% 81.83
Fibonacci 50% 76.71
Last Price 73.08
Fibonacci 38.2% 71.59
52-Week Low 55.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar